Insider · CIK 0002065881
Latha Vairavan
Files at ARQT (Arcutis Biotherapeutics, Inc.). First filing Aug 5, 2025, latest Mar 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARQT: Arcutis Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Arcutis Biotherapeutics, Inc. | $72k 2,853 shares | -3% | +97% from low-21% from high | |
| 23Weak | Arcutis Biotherapeutics, Inc. | $34k 1,320 shares | -2% | +124% from low-18% from high | |
| 17Weak | Arcutis Biotherapeutics, Inc. | $2,175 88 shares | -0% | +184% from low-2% from high | |
| 17Weak | Arcutis Biotherapeutics, Inc. | $1,275 89 shares | -0% | +75% from low-16% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock10b5-1 | +27,000 | $0.00 | $0 | 90,607 | Mar 3, 2026 |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,772 | $25.16 | $70k | 87,835 | Mar 3, 2026 |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -81 | $25.91 | $2,099 | 87,754 | Mar 3, 2026 |
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +70,000 | $0.00 | $0 | 70,000 | Mar 3, 2026 |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,320 | $25.50 | $34k | 63,607 | Feb 4, 2026 |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -88 | $24.72 | $2,175 | 64,927 | Nov 5, 2025 |
| Aug 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -89 | $14.33 | $1,275 | 65,015 | Aug 5, 2025 |
| May 6, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 65,104 | May 7, 2025 |
| May 6, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | May 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.